BridgeMD
New treatment option for Generalized Anxiety Disorder (GAD)
Official title The Effect of Patient Preference for Treatment Model in Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder
ClinicalTrials.gov ID: NCT07201844
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate the effect of allowing patients to choose between two internet-based cognitive behavioral treatments (ICBT) for generalized anxiety disorder (GAD). The goal is also to examine psychologists' ability to predict which of the two treatments the patient will benefit most from.
- Time commitment: about 10 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older.
- Meet diagnostic criteria for GAD according to DSM-5, as assessed by a psychologist on a video-call.
- Self-rated score ≥ 7 on GAD-7.
- Can read and speak Swedish fluently.
- Have access to a smartphone, tablet, or computer and a Swedish BankID which allows access to the video-calls and treatment platform.
You likely can't join if
- Patients that are judged to be in greater need of another psychiatric treatment for another psychiatric diagnosis (for example severe depression)...
- Current drug or alcohol abuse.
- Current severe somatic health concern or social vulnerability if this is judged to be too great an obstacle for the patient to carry out the...
See the full eligibility criteria
- 18 years or older.
- Meet diagnostic criteria for GAD according to DSM-5, as assessed by a psychologist on a video-call.
- Self-rated score ≥ 7 on GAD-7.
- Can read and speak Swedish fluently.
- Have access to a smartphone, tablet, or computer and a Swedish BankID which allows access to the video-calls and treatment platform.
- Have the time and possibility to participate in the 10 week treatment.
- Consents to participate.
- Patients that are judged to be in greater need of another psychiatric treatment for another psychiatric diagnosis (for example severe depression) and/or is judged to have a high risk of suicide.
- Current drug or alcohol abuse.
- Current severe somatic health concern or social vulnerability if this is judged to be too great an obstacle for the patient to carry out the treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sverige, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sverige, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.